MegaProject 904: EBRD considering financing Turkish laboratory PPP
- European Bank for Reconstruction and Development (EBRD)
- CCN Yatirim Holding A.S.
This article is part of a daily series of MegaProjects articles. If you want to know more about PPP projects with a considerable size visit our MegaProjects section. You can receive them by email on a daily basis.
The European Bank for Reconstruction and Development (EBRD) has announced its plans to finance of a Turkish health PPP project.
The EBRD is planning to arrange an A/B loan of up to €250 million (US$267 million) (up to €75 million A-loan and up to €175 million B-loan) for the Bilkent Integrated Healthcare Campus.
The project integrated laboratories campus consists of various administration buildings and different laboratories including different levels of BSL and ABSL laboratories. It includes the design, construction, equipment and maintenance of the facilities for the provision of products and services for Turkish Public Health Institution (TPHA) and Turkish Medicine and Medical Equipment Institution (TPMDA).
Total project costs are estimated at ca. US$1.2 billion.
The EBRD financing will be in parallel with facilities from other international financing institutions and commercial banks.
The Ministry of Health of Turkey awarded the project to CCN Laboratuar Hizmetleri ve Yonetim A.S., a special purpose company incorporated in Turkey and owned by CCN Yatirim Holding A.S.
Under this PPP structure, the concessionaire will supply and maintain the research laboratories, while the provision of the research services within the laboratories will remain the responsibility of the Ministry of Health.
The EBRD aims to increase private sector participation in the healthcare sector in Turkey. In response to the need for large capacity investments in healthcare systems, the Turkish government is seeking to tap private sector resources and know-how to construct and manage infrastructure related facilities more rapidly and more efficiently, while preventive healthcare provision remains under the responsibility of the state.
The project is the first of its kind in the Turkish healthcare market supporting research activities and providing access to high tech laboratories to respond the modern days development technologies, changing environmental conditions, healthcare needs and health risks and treats for the Turkish healthcare system.